Effect of vitamin D3 supplementation on glycated hemoglobin (HbA1c), fructosamine, serum lipids, and body mass index: a randomized, double-blinded, placebo-controlled trial among healthy immigrants living in Norway
Ahmed A Madar, Kirsten V Knutsen, Lars C Stene, Mette Brekke, Haakon E Meyer, Per Lagerløv, Ahmed A Madar, Kirsten V Knutsen, Lars C Stene, Mette Brekke, Haakon E Meyer, Per Lagerløv
Abstract
Objective: Despite the suggested role of vitamin D in the prevention of diabetes and cardiovascular disease or its risk factors, the evidence is not consistent and there is a paucity of randomized controlled trials in this field. We aimed to investigate the effect of 16-week daily vitamin D3 supplementation on glycated hemoglobin (HbA1c), fructosamine, body mass index (BMI), and serum lipids.
Design: Double-blind, randomized, placebo-controlled trial.
Setting: Immigrant community centers in Oslo, Norway.
Participants: 251 healthy adults aged 18-50 years with a non-Western immigrant background. All participants performed the baseline test and 215 (86%) returned to the follow-up test.
Intervention: 16 weeks of daily oral supplementation with either 10 μg vitamin D3, 25 μg vitamin D3, or placebo.
Main outcome measures: Difference in absolute change during the 16-week intervention between the intervention groups combined (10 or 25 μg of vitamin D3/day) and placebo, in HbA1c, fructosamine, serum lipids (total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides), and BMI.
Results: A total of 215 (86%) participants completed the study. Serum 25-hydroxyvitamin D increased from 29 nmol/L at baseline to 49 nmol/L after intervention, with little change in the placebo group. However, there was no difference in change of HbA1c between those receiving vitamin D3 compared with placebo (mean difference: 0.01% (95% CI -0.04 to 0.06, p=0.7)). Neither did the vitamin D3 supplementation have any effect on the other end points: fructosamine, serum lipids, and BMI.
Conclusions: 16-week vitamin D3 supplementation to healthy immigrants from South Asia, the Middle East, or Africa and now living in Norway with low vitamin D status did not improve HbA1c, fructosamine, lipid profiles, or BMI. An updated meta-analysis of similar published trials showed that our results were generally consistent with those of other studies.
Trial registration number: NCT01263288.
Keywords: Body Mass Index; Glycated Hemoglobin; Serum Lipids; Vitamin D.
Figures
References
- Madar AA, Stene LC, Meyer HE. Vitamin D status among immigrant mothers from Pakistan, Turkey and Somalia and their infants attending child health clinics in Norway. Br J Nutr 2009;101:1052–8
- Holvik K, Meyer HE, Haug E, et al. . Prevalence and predictors of vitamin D deficiency in five immigrant groups living in Oslo, Norway: the Oslo Immigrant Health Study. Eur J Clin Nutr 2005;59:57–63
- Andersen R, Molgaard C, Skovgaard LT, et al. . Pakistani immigrant children and adults in Denmark have severely low vitamin D status. Eur J Clin Nutr 2008;62:625–34
- Lips P. Vitamin D status and nutrition in Europe and Asia. J Steroid Biochem Mol Biol 2007;103:620–5
- Bouillon R, Carmeliet G, Verlinden L, et al. . Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008;29:726–76
- Jenum AK, Diep LM, Holmboe-Ottesen G, et al. . Diabetes susceptibility in ethnic minority groups from Turkey, Vietnam, Sri Lanka and Pakistan compared with Norwegians—the association with adiposity is strongest for ethnic minority women. BMC Public Health 2012;12:150.
- Wandell PE, Carlsson A, Steiner KH. Prevalence of diabetes among immigrants in the Nordic countries. Curr Diabetes Rev 2010;6:126–33
- Barnett AH, Dixon AN, Bellary S, et al. . Type 2 diabetes and cardiovascular risk in the UK south Asian community. Diabetologia 2006;49:2234–46
- Tran AT, Straand J, Diep LM, et al. . Cardiovascular disease by diabetes status in five ethnic minority groups compared to ethnic Norwegians. BMC Public Health 2011;11:554.
- Gholap N, Davies M, Patel K, et al. . Type 2 diabetes and cardiovascular disease in South Asians. Prim Care Diabetes 2011;5:45–56
- Pittas AG, Nelson J, Mitri J, et al. . Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention Program. Diabetes Care 2012;35:565–73
- Hutchinson MS, Figenschau Y, Njolstad I, et al. . Serum 25-hydroxyvitamin D levels are inversely associated with glycated haemoglobin (HbA(1c)). The Tromso Study. Scand J Clin Lab Invest 2011;71:399–406
- Jorde R, Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 2011;50:303–12
- Wang TJ, Pencina MJ, Booth SL, et al. . Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503–11
- Knutsen KV, Madar AA, Lagerlov P, et al. . Does vitamin D improve muscle strength in adults? A randomized, double-blind, placebo-controlled trial among ethnic minorities in Norway. J Clin Endocrinol Metab 2014;99:194–202
- Nathan DM, Kuenen J, Borg R, et al. . Translating the A1C assay into estimated average glucose values. Diabetes Care 2008;31:1473–8
- Wright LAC, Hirsch IB. The Challenge of the use of glycemic biomarkers in diabetes: reflecting on hemoglobin A1C, 1,5-anhydroglucitol, and the glycated proteins fructosamine and glycated albumin. Diabetes Spectr 2012;25:141–8
- Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 2009;48:349–54
- Hjellset VT, Bjorge B, Eriksen HR, et al. . Risk factors for type 2 diabetes among female Pakistani immigrants: the InvaDiab-DEPLAN study on Pakistani immigrant women living in Oslo, Norway. J Immigr Minor Health 2011;13:101–10
- Knutsen KV, Brekke M, Gjelstad S, et al. . Vitamin D status in patients with musculoskeletal pain, fatigue and headache: a cross-sectional descriptive study in a multi-ethnic general practice in Norway. Scand J Prim Health Care 2010;28:166–71
- George PS, Pearson ER, Witham MD. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet Med 2012;29:e142–50
- Davidson MB, Duran P, Lee ML, et al. . High-dose vitamin d supplementation in people with prediabetes and hypovitaminosis d. Diabetes Care 2013;36:260–6
- Harris SS, Pittas AG, Palermo NJ. A randomized, placebo-controlled trial of vitamin D supplementation to improve glycaemia in overweight and obese African Americans. Diabetes Obes Metab 2012;14:789–94
- Mitri J, Dawson-Hughes B, Hu FB, et al. . Effects of vitamin D and calcium supplementation on pancreatic beta cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr 2011;94:486–94
- Jorde R, Strand Hutchinson M, Kjaergaard M, et al. . Supplementation with high doses of vitamin D to subjects without vitamin D deficiency may have negative effects: pooled data from four intervention trials in Tromso. ISRN Endocrinol 2013;2013:348705.
- Elamin MB, Abu Elnour NO, Elamin KB, et al. . Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011;96:1931–42
- Andersen R, Brot C, Mejborn H, et al. . Vitamin D supplementation does not affect serum lipids and lipoproteins in Pakistani immigrants. Eur J Clin Nutr 2009;63:1150–3
- Soares MJ, Chan She Ping-Delfos W, Ghanbari MH. Calcium and vitamin D for obesity: a review of randomized controlled trials. Eur J Clin Nutr 2011;65:994–1004
- Wamberg L, Kampmann U, Stodkilde-Jorgensen H, et al. . Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels—results from a randomized trial. Eur J Intern Med 2013;24:644–9
- Sneve M, Figenschau Y, Jorde R. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 2008;159:675–84
Source: PubMed